Repeated administration of autologous tumor-infiltrating lymphocytes (LM103 infusion) alongside immune checkpoint inhibitors results in sustained tumor regression in a patient with advanced mucosal melanoma: a case study and review of existing literature
-
By
-
Fenge Li
-
Yue Xu
-
Yupeng Wang
-
Ning Mu
-
Mei Liu
-
Weihong Feng
-
Yongming Xue
-
Shengnan Wu
-
Xinyi Wang
-
Gregory Lizee
-
Chunhua Ma
-
April 23, 2026
-
0 min
